JP2002527389A5 - - Google Patents

Download PDF

Info

Publication number
JP2002527389A5
JP2002527389A5 JP2000575502A JP2000575502A JP2002527389A5 JP 2002527389 A5 JP2002527389 A5 JP 2002527389A5 JP 2000575502 A JP2000575502 A JP 2000575502A JP 2000575502 A JP2000575502 A JP 2000575502A JP 2002527389 A5 JP2002527389 A5 JP 2002527389A5
Authority
JP
Japan
Prior art keywords
composition according
alkanoyl
vitis
composition
carnitine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000575502A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002527389A (ja
JP4166951B2 (ja
Filing date
Publication date
Priority claimed from IT1998RM000636A external-priority patent/IT1302365B1/it
Application filed filed Critical
Publication of JP2002527389A publication Critical patent/JP2002527389A/ja
Publication of JP2002527389A5 publication Critical patent/JP2002527389A5/ja
Application granted granted Critical
Publication of JP4166951B2 publication Critical patent/JP4166951B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000575502A 1998-10-09 1999-10-06 脳性および加齢性疾患の予防または治療のためのカルニチンおよびレスベラトロールの組み合わせ Expired - Fee Related JP4166951B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT98A000636 1998-10-09
IT1998RM000636A IT1302365B1 (it) 1998-10-09 1998-10-09 Uso di carnitine e resveratrolo per produrre una composizione per laprevenzione o il trattamento terapeutico di alterazioni cerebrali
PCT/IT1999/000311 WO2000021526A1 (en) 1998-10-09 1999-10-06 Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders

Publications (3)

Publication Number Publication Date
JP2002527389A JP2002527389A (ja) 2002-08-27
JP2002527389A5 true JP2002527389A5 (https=) 2005-06-30
JP4166951B2 JP4166951B2 (ja) 2008-10-15

Family

ID=11406160

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000575502A Expired - Fee Related JP4166951B2 (ja) 1998-10-09 1999-10-06 脳性および加齢性疾患の予防または治療のためのカルニチンおよびレスベラトロールの組み合わせ

Country Status (27)

Country Link
US (1) US6515020B1 (https=)
EP (1) EP1117394B1 (https=)
JP (1) JP4166951B2 (https=)
KR (1) KR20010079981A (https=)
CN (1) CN1323205A (https=)
AR (1) AR020762A1 (https=)
AT (1) ATE249823T1 (https=)
AU (1) AU767492B2 (https=)
BR (1) BR9915918A (https=)
CA (1) CA2344893C (https=)
CZ (1) CZ2001920A3 (https=)
DE (1) DE69911441T2 (https=)
DK (1) DK1117394T3 (https=)
EE (1) EE200100205A (https=)
ES (1) ES2207287T3 (https=)
HK (1) HK1040935A1 (https=)
HU (1) HU229364B1 (https=)
IL (1) IL142046A0 (https=)
IS (1) IS5896A (https=)
IT (1) IT1302365B1 (https=)
NO (1) NO20011693L (https=)
PL (1) PL197342B1 (https=)
PT (1) PT1117394E (https=)
SK (1) SK3782001A3 (https=)
TN (1) TNSN99186A1 (https=)
TR (1) TR200100947T2 (https=)
WO (1) WO2000021526A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002047193A (ja) * 2000-07-31 2002-02-12 Sunstar Inc アレルギー性皮膚炎予防または治療用組成物
US20020173549A1 (en) * 2000-11-08 2002-11-21 Wurtman Richard J. Compositions and methods for treatment of mild cognitive impairment
BRPI0106382B1 (pt) * 2001-03-13 2017-07-11 Universidade Do Estado Do Rio De Janeiro - Uerj Process for obtaining decocts from vitis labrusca and vitis vinifera casts, process for obtaining the hydro-alcoholic extract, process for obtaining the hydro-alcoholic extract-ethyl acetate and pharmaceutical compositions
EP1284133B1 (de) * 2001-08-18 2006-10-11 Cognis IP Management GmbH Wirkstoffmischungen
US20070218152A1 (en) * 2002-03-12 2007-09-20 Roberto Moura Process for obtention of decoctions of Vitis labrusca and Vitis vinifera skins
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
KR100574392B1 (ko) * 2003-02-07 2006-05-02 재단법인서울대학교산학협력재단 신경보호활성을 갖는 신규 페닐환 유도체 및 이를함유하는 약학 조성물
US20060025337A1 (en) * 2003-07-01 2006-02-02 President And Fellows Of Harvard College Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
CA2529510A1 (en) * 2003-07-01 2005-01-13 President And Fellows Of Harvard College Compositions for manipulating the lifespan and stress response of cells and organisms
KR100543056B1 (ko) * 2003-11-07 2006-01-20 (주)네추럴에프앤피 신경세포 보호 활성이 있는 포도씨 추출물을 포함하는뇌질환 예방 및 치료용 조성물
EP1708689A2 (en) 2003-12-29 2006-10-11 The President and Fellows of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
ES2245609B1 (es) * 2004-06-18 2007-08-16 Universidad De Barcelona Nuevo agente terapeutico para el tratamiento de la infertilidad y/o subfertilidad masculina en mamiferos.
US20060014705A1 (en) * 2004-06-30 2006-01-19 Howitz Konrad T Compositions and methods for selectively activating human sirtuins
US20060121137A1 (en) * 2004-12-07 2006-06-08 Hartle Diane K Muscadine grape pomace in the treatment of intestinal inflammation
JP2008527002A (ja) * 2005-01-13 2008-07-24 サートリス ファーマシューティカルズ, インコーポレイテッド 神経変性障害および血液凝固障害を予防および処置するための新規組成物
WO2006138418A2 (en) * 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
WO2007049796A2 (en) * 2005-10-26 2007-05-03 Kao Corporation Resveratrol and/or grape leaf extract as i. a. endurance improver, anti-aging agent, muscle strength improver
FR2898493B1 (fr) * 2006-03-16 2008-08-08 Af Consulting Compositions cosmetiques, pharmaceutiques, alimentaires et veterinaires dont l'action d'activation de genes de type sirtuin permet de retarder le vieillissement des mammiferes et ses effets nefastes
US20120016037A1 (en) * 2006-07-24 2012-01-19 Frank Toppo Method for prevention and treatment of Alzheimers
EP2124985A4 (en) * 2007-01-26 2011-06-08 Univ Washington METHOD AND COMPOSITIONS FOR TREATING NERVOUS ELEMENTS
AT506014A1 (de) * 2007-10-24 2009-05-15 Karl Mag Dr Zehethofer Functional drink
MX2012014127A (es) * 2010-06-16 2013-06-28 Sigma Tau Ind Farmaceuti Acetil-carnitina para uso en un metodo para incrementar neurogenesis en tejido nervioso.
KR101327936B1 (ko) * 2011-07-06 2013-11-13 한국식품연구원 옥시레스베라트롤 이민 유도체를 유효성분으로 함유하는 뇌신경보호 효과를 가지는 조성물
CN102919943A (zh) * 2012-10-26 2013-02-13 郑全辉 保健饮品-葡藤素
CN103877170B (zh) * 2012-12-19 2015-11-04 中国医学科学院药用植物研究所 一种虎杖的乙酸乙酯提取物及其制备方法和应用
CN119424497B (zh) * 2025-01-08 2025-06-24 万邦德制药集团有限公司 一种用于防治阿尔茨海默病、皮肤光老化的组合物、制剂及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
JP2001511153A (ja) 1997-02-04 2001-08-07 ブイ. コスバブ,ジョン 血管変性性疾患の予防および処置のための組成物および方法
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
CH692837A5 (it) * 1997-07-02 2002-11-29 Lisapharma Spa Composizione farmaceutica per uso alimentare, dietetico o medicinale adatta a migliorare l'assorbimento orale dei polifenoli e particolarmente del resveratrolo presenti nell'uva e nei suoi p
US5904924A (en) 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition
AU4084599A (en) * 1998-05-18 1999-12-06 Oklahoma Medical Research Foundation Resveratrol inhibition of myeloperoxidase

Similar Documents

Publication Publication Date Title
JP2002527389A5 (https=)
DE69730604T2 (de) Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen
DE69502147T2 (de) L-Carnitin Salz und dieses enthaltende Zusammensetzungen
JP4104180B2 (ja) リパーゼ活性促進剤
KR970032854A (ko) L-카르니틴 또는 알카노일 l-카르니틴을 함유하는 지질대사장애 질환의 예방 및 치료에 유효한 약제조성물
JPH11335233A (ja) メラニン生成抑制剤及び化粧料組成物
JPH11246336A (ja) 活性酸素消去剤及び美肌化粧料組成物
WO2005041996A1 (en) Lotus and methyl donors
WO2011094016A1 (en) Compounds, compositions and methods for preventing skin darkening
JP2005082522A (ja) 美白化粧料
DE60124769T2 (de) Nahrungsergänzung mit schlankheitseffekt
JP2003081744A (ja) 抗酸化剤
WO2000015187A1 (de) Kreatin und/oder kreatinderivate als feuchthaltemittel enthaltende kosmetische zubereitungen
KR102292669B1 (ko) 항염, 항산화 및 미백 효과가 우수한 화장료, 이의 제조방법 및 이를 포함하는 화장품
JPH09221410A (ja) 老化防止用皮膚外用剤
EP0911019B1 (de) Desodorierende Zubereitungen auf der Basis von Flavonderivaten und/oder Flavanonderivaten, insbesondere von Flavonoiden
KR20100130109A (ko) 식용버섯 자실체 추출물을 유효성분으로 함유하는 피부미백용 화장료 조성물
JP4253296B2 (ja) 健康美容食品
JP7716862B2 (ja) 皮膚状態改善剤
JP6831549B2 (ja) Abca12遺伝子発現促進剤
KR101668029B1 (ko) 라파콜을 유효성분으로 포함하는 주름개선용 화장료 조성물
EP3027166A2 (de) Formulierungen enthaltend sphinganin
KR102416399B1 (ko) 숙지황, 맥문동, 천문동 및 자초의 혼합 추출물을 함유하는 피부 주름 개선용 화장료 조성물
KR101050484B1 (ko) 락톤계 화합물을 유효성분으로 함유하는 피부 미백용 조성물
EP2072038A2 (de) Wirkstoffkombinationen aus Anisfruchtextrakt und einem oder mehreren 2,3-Dibenzylbutyrolactonen